UK: Innovative Approaches To Improving Global Access To Palliative And End-Of-Life Care

Last Updated: 9 February 2017
Article by Mark Steedman

I am delighted to use this week's blog to introduce the Centre's new Manager, Mark Steedman. After studying bioengineering and completing a PhD in the San Francisco Bay Area and a two-year postdoctoral research fellowship in London, Mark has spent the past four years analysing global health policy. His recent work has involved research into topics such as palliative and end-of-life care, maternal and newborn health, design in healthcare and electronic health records. His blog this week focusses on his background researching innovative approaches to improving access to palliative and end-of-life care, a topic we explored recently in our report Vital Signs: how to deliver better healthcare across Europe, in 2014 in our report Transforming care at the end-of-life and in 2013 in the report Dying Healed: transforming end-of-life care through innovation, which Mark and I co-authored for the 2013 World Innovation Summit for Health.

My first visit to a hospice

I visited a hospice for the first time in 2013 as I began researching the often neglected area of palliative and end-of-life care. I was out of my comfort zone, as up until then I had always worked in a laboratory setting. The materials, devices and experimental tools I had worked with every day as a bioengineer were inanimate objects that displayed no human emotion. Speaking to hospice patients was the opposite. For a few hours that afternoon, I shadowed a palliative care physician and interacted with several hospice patients, carers and family members, entranced by an experience that would shape my career for the next several years.

The first thing I learned about dying is that for every individual it is different – the wishes and desires of one person are unique to that individual. While one patient may struggle to accept a diagnosis or current state of health, another may only care about what happens after death – to a family member, personal finances or about other practical matters. Adapting to these differences and determining the best course of action or treatment for each patient is one of the biggest challenges a palliative care physician faces, and this was something I witnessed first-hand.

Global access to end-of-life care

Over the next few months, as I researched and improved my own knowledge and understanding about the global state of end-of-life care, I discovered some sobering facts. Approximately 55 million people die every year, but access to care at the end-of-life, particularly to pain control, is grossly inequitable around the world.1 The best data we have for pain control is through the use of morphine, and the discrepancy between high-income and low-income countries is staggering. Research suggests that 94 per cent of the world's morphine is consumed in high-income countries, which account for only 15 per cent of the world's population.2

Furthermore, the average amount of oral morphine (or equivalents) consumed by a patient suffering from cancer or AIDS in the richest 10% of countries is 99,000 mg. In the poorest 10 per cent of countries, this number is only 200 mg.3 A lack of resources and skilled healthcare staff alongside fear of illicit drug use have led to overly restrictive regulations such as dose limits, special permissions for prescribing and receiving opioids and other barriers, which account for this discrepancy.4 Overcoming these barriers, and integrating palliative and end-of-life care into the international campaign for universal health coverage has become a central theme of the global health agenda, as exemplified by a World Health Assembly resolution in 2014.5

Witnessing end-of-life care in a global context

My research on access to morphine and other aspects of end-of-life care was put into context when I visited a palliative care ward in a hospital in northeast Thailand in early 2014. Staffed by one physician and five nurses, the ward was constantly at capacity and had no access to morphine. As most of their patients were facing advanced stage cancer, the inability to easily relieve their patients' pain was a constant challenge. However, all patients were treated with the dignity they deserved, local traditions were respected and staff were actively involved in seeking out new training opportunities and other ways to best treat their patients.

Adopting innovative approaches to end-of-life care

The need for innovative approaches to end-of-life care has gained traction around the world, with some low- and middle-income countries leading the way. Nigeria has had some success introducing an inexpensive version of oral morphine at a major hospital, overcoming years of roadblocks.6 Uganda has been able to establish a national oral morphine production programme, despite its high levels of poverty.7 Early success in the state of Kerala, India, in distributing palliative care through a community-based model eventually led India's parliament to approve changes to the Narcotic Drugs and Psychotropic Substances Act of 1985 that had resulted in a 97 per cent decrease in the use of morphine across the country.8,9 Additionally, numerous countries have piloted innovative education and training programmes, targeting everyone from medical students through to experienced doctors and nurses.10

These are just a few of the numerous examples of innovative approaches creating better access to end-of-life care around the world. However, these are small steps in a long journey to equity in access to care at the end-of-life. As I begin my work with the Centre for Health Solutions, I look forward to finding synergies linking my background in end-of-life care and other healthcare challenges to the Centre's remit to generate insight and thought leadership across the life sciences and healthcare industry.

Footnotes

1.Worldwide Palliative Care Alliance and WHO. Global atlas of palliative care at the end of life. http://www.who.int/nmh/Global_Atlas_of_Palliative_Care.pdf; January, 2014.

2.Knaul, FM, Farmer, PE, Bhadelia, A, Berman, P, Horton, R. Closing the divide: the Harvard Global Equity Initiative-Lancet Commission on global access to pain control and palliative care. The Lancet. 2015; 386: 9995: 722-724.

3.Knaul, FM, Adami, HO, Adebamowo, C, Arreola-Ornelas, H, Berger, AJ, and Bhadelia, A. The global cancer divide: an equity imperative. in: FM Knaul, R Gralow, R Atun, A Bhadelia (Eds.) Closing the cancer divide: an equity imperative. Harvard Global Equity Initiative, Cambridge, MA; 2012: 29–60.

4.Global Opioid Policy Initiative: Regulatory Barriers. http://www.esmo.org/Policy/Global-Opioid-Policy-Initiative/Infographics/Regulatory-Barriers.

5.WHO. Resolution WHA 67/19. Strengthening of palliative care as a component of comprehensive care throughout the life course. http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R19-en.pdf; May, 2014.

6.Nigeria: Cost of oral morphine at the National Hospital Abuja reduced by 81%. http://www.ehospice.com/Default/tabid/10686/ArticleId/5884.

7.Merriman, A and Harding, R. Pain control in the African context: the Ugandan introduction of affordable morphine to relieve suffering at the end of life. Philos Ethics Humanit Med. 2010; 5:10.

8.Kumar, SK. Kerala, India: A regional community-based palliative care model. J Pain Symp Manage. 2007; 33: 623-627.

9.Kmietowicz, Z. Indian parliament votes to increase access to morphine. BMJ. 2014; 348: g1744

10.Steedman, MR, Hughes-Hallett, T, Knaul, FM, Knuth, A, Shamieh, O, and Darzi, A. Innovation can improve and expand aspects of end-of-life care in low- and middle-income countries. Health Aff (Millwood). 2014; 33: 1612–1619.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Topics
 
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions